| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.134 | 71.951 | 4.794 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 6.134 | 72.358 | 4.959 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 4.975 | 29.747 | 2.151 | 577 | 1.315 | 439 | 414 | 10 | 10 | 10 |
| Gross Profit/Loss - EUR | 1.159 | 42.612 | 2.809 | -577 | -1.315 | -439 | -414 | -10 | -10 | -10 |
| Net Profit/Loss - EUR | 973 | 35.792 | 2.359 | -577 | -1.315 | -439 | -414 | -10 | -10 | -10 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Taomed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.628 | 977 | 388 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 5.363 | 41.605 | 5.112 | 2.289 | 930 | 473 | 250 | 241 | 432 | 420 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 10 | 163 | 171 | 178 | 179 | 175 | 176 | 175 | 174 |
| Cash | 5.363 | 41.595 | 4.948 | 2.117 | 752 | 294 | 75 | 65 | 257 | 245 |
| Shareholders Funds | -337 | 35.458 | 5.279 | 2.289 | 930 | 473 | 48 | 38 | 28 | 17 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.328 | 7.123 | 221 | 0 | 0 | 0 | 202 | 203 | 404 | 402 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
6202
|
|||||||||
Comments - Taomed S.r.l.